Home  >  Products  >  IL17A (interleukin 17A) Blocking Peptide (the N terminal of IL17A)(100ug)
IL17A (interleukin 17A) Blocking Peptide (the N terminal of IL17A)(100ug)

IL17A (interleukin 17A) Blocking Peptide (the N terminal of IL17A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IL17A Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59132
Size: 100ug
Weight: 15kDa
Gene: 3605
Format: Lyophilized powder
Target: The protein encoded by this gene is a proinflammatory cytokine produced by activated T cells. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.
Alternative names: CTLA8; IL-17; IL-17A; IL17
See Full Product Listings >